Abstracts tagged "fibromyalgia and pain"

Abstract Number: 235 • 2019 ACR/ARP Annual Meeting
Muscle Pressure Correlates with Pain Levels in Fibromyalgia Patients and Muscle Tension May Be the Cause of Their Pain
Alexandra Katz Small¹, Ben Small ², Josephine Anilao ², Jessica Polyak Wokurka ³ and Robert Katz ⁴, ¹Rush University Medical Center, Chicago, ²Rheumatology Associates, Chicago, IL, ³Rheumatology Associates, Chicago, ⁴Rush University Medical Center, Chicago, IL
Background/Purpose: Previous research has found that muscle pressure as measured by a pressure gauge is three times higher in the trapezius muscle in fibromyalgia patients…
Abstract Number: 236 • 2019 ACR/ARP Annual Meeting
Repeat Muscle Pressures Measured in Fibromyalgia Patients and Compared with Pain Scores
Alexandra Katz Small¹, Ben Small ² and Robert Katz ³, ¹Rush University Medical Center, Chicago, ²Rheumatology Associates, Chicago, IL, ³Rush University Medical Center, Chicago, IL
Background/Purpose: Patients meeting the ACR criteria for the diagnosis of fibromyalgia were evaluated for intramuscular pressure using a pressure gauge from a trained physician or…
Abstract Number: 1870 • 2017 ACR/ARHP Annual Meeting
Validation of an Electronic Version of the Michigan Body Map
Chad M. Brummett¹, David Kohns², Rishi Bakshi³, Jenna Goesling⁴, Stephanie Moser¹, Jennifer Pierce⁴, David Williams⁵, Daniel J. Clauw⁵, Afton L. Hassett¹ and Erin Spencer², ¹Anesthesiology, University of Michigan, Ann Arbor, MI, ²University of Michigan, Ann Arbor, MI, ³Physical Medicine Rehabilitaion, Univeristy of Michigan, Ann Arbor, MI, ⁴Department of Anesthesiology, University of Michigan, Ann Arbor, MI, ⁵Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI
Background/Purpose: We previously validated the Michigan Body Map (MBM) to accurately assess widespread body pain and as a means of administering the Widespread Pain Index…
Abstract Number: 1871 • 2017 ACR/ARHP Annual Meeting
Identifying Pain Sites Highly Associated with the Fibromyalgia (FM) Phenotype
Louis Lu¹, Stephanie Moser², Chad M. Brummett² and Daniel J. Clauw³, ¹Anesthesiology & Perioperative Care, UC Irvine, Orange, CA, ²Anesthesiology, University of Michigan, Ann Arbor, MI, ³Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI
Background/Purpose: Fibromyalgia is challenging to diagnose given its overlapping symptoms with other chronic pain conditions. The most characteristic feature of FM is widespread pain, operationalized…
Abstract Number: 1977 • 2017 ACR/ARHP Annual Meeting
Elevated Levels of Eotaxin-2 in Serum of Fibromyalgia Patients
Victoria Furer¹, Eyal Hazan², Adi Mor³, Michal Segal³, Avi Katav³, Valerie Aloush⁴, Ori Elkayam⁴, Jacob George^3,5 and Jacob N. Ablin^6,7, ¹Rheumatology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel, ²Internal Medicine D, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, ³ChemomAb Ltd. Israel, Tel Aviv, Israel, ⁴Rheumatology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, ⁵Heart Institute, Kaplan Medical Center, Rehovot, Israel, ⁶Internal Medicine H, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, ⁷Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Background/Purpose: Fibromyalgia is a widespread chronic pain syndrome (FMS) the pathogenesis of which remains incompletely understood. FMS patients demonstrate an altered profile of chemokines relative…
Abstract Number: 2205 • 2016 ACR/ARHP Annual Meeting
Cognitive Functioning in Fibromyalgia: The Central Role of Effort
Jacob Ablin¹, Tamar Bar On –Kalfon², Gilad Gal³ and Ran Shorer², ¹Rheumatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel, ²Rheumatology, Tel Aviv Sourasky medical center, Tel Aviv, Israel, ³School of Behavioral Sciences, Tel Aviv-Jaffa Academic College, Tel Aviv, Israel
Background/Purpose: Fibromyalgia syndrome (FMS) patients demonstrate deficits in tests of attention, executive functioning and verbal memory. We assessed the role of effort in the cognitive…
Abstract Number: 2736 • 2016 ACR/ARHP Annual Meeting
Do Validated Tools of Disease Activity in Ankylosing Spondylitis Measure Fibromyalgia Pain?
Marina N. Magrey¹, Sherilyn Diomampo² and Muhammad Asim Khan³, ¹Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH, ²MetroHealth Medical Center, Cleveland, OH, ³Medicine/ Rheumatology, Case Western Reserve Univ, Cleveland, OH
Background/Purpose: Concomitant fibromyalgia syndrome (FMS) is a common problem in ankylosing spondylitis (AS) and its recognition is important for optimal management. BASDAI, a disease activity…
Abstract Number: 71 • 2015 ACR/ARHP Annual Meeting
Fibromyalgia Dysautonomia and Distress. Correlation Between the Newly Developed Composite Autonomic Symptoms (COMPASS-31) Questionnaire and the Fibromyalgia Polysymptomatic Distress Scale
Laura-Aline Martinez-Martinez¹, Maya Chacón Pérez², Paola Reyes-Loyola³ and Manuel Martínez-Lavín³, ¹National Institute of Cardiology. Mexico, Mexico City, TX, Mexico, ²National Institute of Cardiology, Mexico City, Mexico, ³National Institute of Cardiology. Mexico, Mexico City, Mexico
Background/Purpose: A consistent line of investigation suggests that dysautonomia may explain the multisystem fibromyalgia features, and that fibromyalgia is a sympathetically maintained neuropathic pain syndrome.…
Abstract Number: 75 • 2015 ACR/ARHP Annual Meeting
Fibromyalgia and Positional Cervical Cord Compression Differ Only By Autonomic Nervous System Consequences: A Double-Blinded, Prospective Study
Andrew Holman, Pacific Rheumatology Reseach, Seattle, WA
Background/Purpose: In 1998, C Muhle and D Resnick proposed a corollary to cervical spinal stenosis caused by intermittent abutment of the cervical spinal cord from…
Abstract Number: 915 • 2015 ACR/ARHP Annual Meeting
Defining Pain for Fibromyalgia Criteria: Multi-Site or Widespread? an Analysis of Data from Four UK Population-Based Studies
Gary J. Macfarlane¹, Linda E. Dean¹, Robert Bennett², Leslie J. Crofford³, Abimbola Ayorinde¹, Elisa Fluess¹, Daniel J. Clauw⁴, Mary-Ann Fitzcharles⁵, Don Goldenberg⁶, Eduardo Paiva⁷, Roland Staud⁸ and Lesley Arnold⁹, ¹Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, ²SN-Office of Research & Development, Oregon Health & Science Univ, Portland, OR, ³Medicine, Vanderbilt University, Nashville, TN, ⁴Anesthesiology, University of Michigan, Ann Arbor, MI, ⁵MGH, Montreal, QC, Canada, ⁶Newton-Wellesley Hospital, Newton, MA, ⁷Sociedade Brasileira de Reumatologia, São Paulo, Brazil, ⁸University of Florida, Gainesville, FL, ⁹University of Cincinnati, Cincinnati, OH
Background/Purpose: The 1990 criteria for fibromyalgia (FM) remain the only set approved by the American College of Rheumatology (ACR). They require that pain be both…
Abstract Number: 1019 • 2015 ACR/ARHP Annual Meeting
Brain Functional Connectivity Differentially Predicts Response to Two Centrally Acting Analgesics in Fibromyalgia
Eric Ichesco¹, Johnson Hampson², Lynne Pauer³, Andrew Clair⁴, Tobias Schmidt-Wilcke⁵, David A. Williams⁶, Daniel J. Clauw² and Richard E. Harris¹, ¹Anesthesiology, U. Michigan, Ann Arbor, MI, ²Anesthesiology, University of Michigan, Ann Arbor, MI, ³Pfizer Inc, New London, CT, ⁴Pfizer Inc., New York, NY, ⁵Bergmannsheil, Bochum, Germany, ⁶Anesthseiology, University of Michigan, Ann Arbor, MI
Background/Purpose: Recently, several functional brain imaging techniques including functional magnetic resonance imaging (fMRI) have been proposed to be useful in probing the mechanisms of action…
Abstract Number: 2290 • 2015 ACR/ARHP Annual Meeting
The 2011 Fibromyalgia (FM) Survey Criteria Are a Surrogate Measure of Pain Centralization
Steven E. Harte¹, Daniel J. Clauw², Andrew D. Clauw¹, J. Ryan Scott¹, Stephanie Moser¹ and Chad Brummett², ¹Department of Anesthesiology, University of Michigan, Ann Arbor, MI, ²Anesthesiology, University of Michigan, Ann Arbor, MI
Background/Purpose: The 2011 FM Survey Criteria can either be used as a dichotomous measure to diagnose an individual with FM, or in a continuous manner…
Abstract Number: 895 • 2014 ACR/ARHP Annual Meeting
The Fibromyalgia Syndrome and Widespread Pain Frequency in Active Duty U.S. Service Members with Posttraumatic Stress Disorder
Bernard Hildebrand¹, Jay B. Higgs¹, Douglas Williamson², Edna Foa³, Patricia Resick⁴, Jim Mintz², Antoinette Brundige², Kevin Kelly⁵, Adam Borah⁵, Stacey Young-McCaughan², Brett Litz⁶, Elizabeth Hembree³ and Alan Peterson², ¹Rheumatology, San Antonio Military Medical Center, JBSA - Fort Sam Houston, TX, ²The University of Texas Health Science Center at San Antonio, San Antonio, TX, ³University of Pennsylvania, Philadelphia, PA, ⁴Duke University, Durham, NC, ⁵Carl R. Darnall Army Medical Center, Fort Hood, TX, ⁶VA Boston Healthcare System, Boston, MA
Background/Purpose: Posttraumatic stress disorder (PTSD) and pain are common amongst US military service members who have deployed to Iraq and Afghanistan. Studies suggest the co-morbidity…
Abstract Number: 892 • 2014 ACR/ARHP Annual Meeting
Symptom Increase in Fibromyalgia Is Not Consistent with the Central Sensitization or Central Hyperresponsiveness Hypothesis
Frederick Wolfe¹, Brian T. Walitt², Johannes Rasker³, Robert S. Katz⁴ and Winfried Häuser⁵, ¹National Data Bank for Rheumatic Diseases, Wichita, KS, ²Rheumatology, Washington Hospital Center, Washington, DC, ³Dpt. Psychology, Health and Technology, University Twente, Enschede, Netherlands, ⁴Rush Medical College, Chicago, IL, ⁵Klinikum Saarbrücken, Saarbrücken, Germany
Background/Purpose: The current dominant hypothesis explains fibromyalgia (FM) as a centralized pain state in which the CNS originates or amplifies pain, which is then accompanied…
Abstract Number: 2080 • 2014 ACR/ARHP Annual Meeting
Carryover Effects in Crossover Design Studies in Fibromyalgia and Other Pain Conditions
Lynne Pauer¹, Birol Emir², Ed Whalen³, Joseph Scavone⁴ and Andrew Clair², ¹445 Eastern Point Road, Pfizer Inc, Groton, CT, ²Pfizer Inc, New York, NY, ³Pfizer Inc., New York, NY, ⁴Pfizer Inc, Groton, CT
Background/Purpose: Explore carryover effects and their influence on crossover and randomized withdrawal design (RWD) studies.Methods: We examine pregabalin crossover and RWD studies in fibromyalgia (FM),…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.